Difficulty: Medium
Average Score: 64%
Practice
Natalizumab is indicated in the treatment of refractory:
Correct answer
D
Rationale
Natalizumab is a monoclonal antibody that targets the ╬▒4-integrin subunit on leukocytes, preventing their migration across the blood-brain barrier. This mechanism of action makes it a crucial treatment for multiple sclerosis (MS), specifically the relapsing-remitting form.
Choosing option D as the correct answer is supported by the fact that natalizumab has been approved by the FDA for the treatment of relapsing forms of MS. It is effective in reducing relapse rates and delaying disease progression in MS patients.
Options A, B, and C can be ruled out as incorrect answers due to the lack of indication for natalizumab in these conditions. Rheumatoid arthritis is commonly treated with disease-modifying anti-rheumatic drugs (DMARDs) like methotrexate. Eczema is managed with topical steroids and immunomodulators, while asthma is treated with bronchodilators, corticosteroids, and other anti-inflammatory medications.
In an educational context, understanding the correct use of medications in specific disease conditions is crucial for healthcare professionals. This question highlights the importance of matching the mechanism of action of a drug with the pathophysiology of the disease it is intended to treat. It also emphasizes the significance of evidence-based practice in selecting appropriate treatments for patients to achieve optimal outcomes.
Choosing option D as the correct answer is supported by the fact that natalizumab has been approved by the FDA for the treatment of relapsing forms of MS. It is effective in reducing relapse rates and delaying disease progression in MS patients.
Options A, B, and C can be ruled out as incorrect answers due to the lack of indication for natalizumab in these conditions. Rheumatoid arthritis is commonly treated with disease-modifying anti-rheumatic drugs (DMARDs) like methotrexate. Eczema is managed with topical steroids and immunomodulators, while asthma is treated with bronchodilators, corticosteroids, and other anti-inflammatory medications.
In an educational context, understanding the correct use of medications in specific disease conditions is crucial for healthcare professionals. This question highlights the importance of matching the mechanism of action of a drug with the pathophysiology of the disease it is intended to treat. It also emphasizes the significance of evidence-based practice in selecting appropriate treatments for patients to achieve optimal outcomes.